Search results for "cardiovascolare"

showing 10 items of 338 documents

Morning and smooth 24-h ambulatory blood pressure control is not achieved in general practice: results from the SURGE observational study.

2013

BACKGROUND The aim of this large-scale, practice-based observational study [Survey with HBPM and ABPM Under Real clinical conditions in General practice to Evaluate BP control in the early morning (SURGE)] was to ascertain the degree of morning and 24-h ambulatory blood pressure (ABP) control in hypertensive patients. METHODS Hypertensive patients [with uncontrolled clinic blood pressure (BP) >140/90 mmHg at screening] from nine different countries were included. Ambulatory BP monitoring was performed over 24 h at 15-min intervals during the day and at 20-min intervals during the night. Assessments included morning (0600-1159 h) and daytime ABP control (BP < 135/85 mmHg), and 24-h ABP contr…

medicine.medical_specialtyAmbulatory blood pressuregenetic structuresPhysiologyGeneral PracticeBlood PressureLeft ventricular hypertrophyHydrochlorothiazideAmbulatory careDiabetes mellitusInternal medicineInternal MedicinemedicineAmbulatory CareHumansMorningbusiness.industryMED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREmedicine.diseaseambulatory blood pressure monitoring hydrochlorothiazide telmisartanBlood pressureEndocrinologyTelmisartanCardiology and Cardiovascular Medicinebusinessmedicine.drugJournal of hypertension
researchProduct

Metabolic syndrome and peripheral arterial disease.

2014

medicine.medical_specialtyArterial diseasebusiness.industryInternal medicinemedicineCardiologyGeneral MedicineMetabolic syndromebusinessmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareMetabolic syndrome peripheral arterial diseasePeripheralRevista clinica espanola
researchProduct

Classification of coronary artery bifurcation lesions and treatments: time for a consensus

2008

Background: Percutaneous coronary intervention (PCI) of coronary bifurcation lesions remains a subject of debate. Many studies have been published in this setting. They are often small scale and display methodological flaws and other shortcomings such as inaccurate designation of lesions, heterogeneity, and inadequate description of techniques implemented. Methods: The aim is to propose a consensus established by the European Bifurcation Club (EBC), on the definition and classification of bifurcation lesions and treatments implemented with the purpose of allowing comparisons between techniques in various anatomical and clinical settings. Results: A bifurcation lesion is a coronary artery na…

medicine.medical_specialtyBifurcation lesionmedicine.medical_treatmentCoronary AngiographyLesionProsthesis Implantationbifurcation lesionsAngioplastyTerminology as TopicmedicineHumansRadiology Nuclear Medicine and imagingclassification of bifurcation lesionsAngioplasty Balloon CoronaryClassification of bifurcation lesionBifurcationQCA.QCAbusiness.industryCoronary StenosisPercutaneous coronary interventionStentGeneral MedicineClassification of treatmentmedicine.anatomical_structureHomogeneousConventional PCISettore MED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREStentsRadiologymedicine.symptomCardiology and Cardiovascular MedicinebusinessArtery
researchProduct

Atherosclerosis, degenerative aortic stenosis and statins

2009

Aortic stenosis is the most common valvular heart disease among adult subjects in western countries The current treatment for aortic stenosis is aortic valve replacement. The possibility of a medical treatment that can slow the progression of aortic stenosis is very fascinating and statins have been tested to reduce the progression of degenerative aortic stenosis (DAS). The rationale for statin treatment in DAS has a deep pathophysiological substrate, in fact inflammation and lipid infiltration constitute the same histopathological pattern of both aortic stenosis and atherosclerosis and these two conditions have the same risk factors. Whether retrospective studies have shown some efficacy o…

medicine.medical_specialtyClinical BiochemistryInflammationlaw.inventionCoronary artery diseaseRandomized controlled trialAortic valve replacementlawInternal medicineDrug DiscoverymedicineAnimalsHumansPharmacologyEvidence-Based Medicinebusiness.industryvalvular heart diseaseRetrospective cohort studyAortic Valve Stenosismedicine.diseaseAtherosclerosisSettore MED/11 - Malattie Dell'Apparato Cardiovascolareatherosclerosis aortic stenosis statinStenosiscardiovascular systemCardiologyMolecular Medicinemedicine.symptomHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessCalcification
researchProduct

A rare case of a coronary artery anomaly detected on multidetector computed tomography

2013

An anomalous aortic origin of the coronary artery arising from the opposite sinus with an interarterial course is a rare condition that is associated with a high risk of sudden cardiac death during or after strenuous exertion. We herein report the case of a 47-year-old woman presenting with chest pain, syncope and palpitations who presented with a rare coronary artery anomaly on multidetector computed tomography coronary artery (MDCT-CA) with prospective electrocardiogram (ECG) gating.

medicine.medical_specialtyCoronary Vessel AnomaliesChest painSudden deathSudden cardiac deathElectrocardiographyInternal medicineMultidetector computed tomographyCoronary artery anomalyMultidetector Computed TomographyInternal MedicinePalpitationsMedicineHumanscardiovascular diseasesSinus (anatomy)business.industryGeneral MedicineMiddle Agedmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato Cardiovascolaremedicine.anatomical_structurecardiovascular systemCardiologyExercise TestFemalemedicine.symptombusinesscoronary anomalies coronary computed tomography sudden deathArtery
researchProduct

Absence of residual vein thrombosis after an episode of idiopatic deep vein thrombosis: short-term anticoagulation is safe. The extended DACUS Study

2009

Abstract Background. The optimal duration of Oral Anticoagulant Therapy (OAT) for Deep Vein Thrombosis (DVT) can be tailored by Residual Vein Thrombosis (RVT) (Siragusa S et al. Blood2003;102(11):OC183), a marker able to assess the individual risk for recurrent thrombosis. However, in patients with idiopathic DVT the safety of early interruption of OAT, because of absence of RVT, is still debated. Objective of the study. In the present study, we evaluated the safety of withholding OAT, in patients with idiopathic DVT and without RVT, three months after the index thrombotic episode. Study design. Prospective controlled study with two groups: patients without RVT stopped OAT after 3 months wh…

medicine.medical_specialtyDeep veinImmunologyPopulationThrombophiliaBiochemistrydeep vein thombosis anticoagulationSettore MED/15 - Malattie Del SanguemedicineVeineducationFirst episodeeducation.field_of_studyresidual vein thrombosisbusiness.industrydeep vein thrombosiCell BiologyHematologymedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareThrombosisSurgeryPulmonary embolismVenous thrombosismedicine.anatomical_structurebusiness
researchProduct

Giant left atrium: a condition that is rarely seen today.

2008

Today, giant left atrium is a condition that is rarely observed in clinical practice and diagnosis can be missed. It is prevalent in patients with rheumatic heart disease that has decreased considerably in industrialized countries in the last two decades. However, the immigration flow in the current era can revive its incidence.

medicine.medical_specialtyHeart diseasebusiness.industryGeneral surgeryIncidence (epidemiology)fungiRheumatic Heart Diseasefood and beveragesCardiomegalyGeneral MedicineMiddle AgedGiant left atriummedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareClinical PracticeMedicineHumansIn patientFemaleHeart AtriaCardiology and Cardiovascular MedicinebusinessGiant left atriumJournal of cardiovascular medicine (Hagerstown, Md.)
researchProduct

Pharmacological Therapy in Children with Atrial Fibrillation and Atrial Flutter

2008

Heart rhythm disorders in children are not different, on electrocardiographic trace, from heart rhythm disorders in adults with the exception of incidence which is different according to the age. Paticularly, atrial flutter (FlA) and fibrillation (FA) are very uncommon arrhythmias in the general pediatric population. Generally atrial fibrillation and atrial flutter, in our experience, is a temporary heart rhythm disturbance connected to specifical and resovable reasons with the exception of Fontains surgical correction of congenital heart diseases or cardiopathies with dilatation of both atria. Presenting symptoms, symptom history (e.g., frequency, duration, and severity), risk assessment, …

medicine.medical_specialtyHeart diseasemedicine.medical_treatmentAdrenergic beta-AntagonistsElectric CountershockPHARMACOLOGICAL THERAPY IN CHILDREN WITH ATRIAL FIBRILLATION AND ATRIAL FLUTTER.Catheter ablationElectrocardiographyPharmacotherapyInternal medicineAtrial FibrillationDrug DiscoverymedicineHumanscardiovascular diseasesChildUltrasonographyPharmacologyFibrillationmedicine.diagnostic_testbusiness.industryIncidence (epidemiology)Cardiac Pacing ArtificialAtrial fibrillationCalcium Channel Blockersmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareAtrial fibrillation atrial flutter pharmacological therapy childrenAtrial FlutterChronic DiseaseCatheter Ablationcardiovascular systemCardiologymedicine.symptombusinessAnti-Arrhythmia AgentsElectrocardiographyAtrial flutterCurrent Pharmaceutical Design
researchProduct

Cardiovascular comorbidity in multiple sclerosis patients treated with mitoxantrone therapy: a cohort study

2017

Abstract Background Mitoxantrone (MX) has been used as second line therapy for aggressive multiple sclerosis (MS). Potential cardiotoxic effects of MX limit its use; a cumulative dose of up to 100 mg/m2, has been long considered relatively safe. We calculated the frequency of cardiac side effects in MS patients treated with MX. Methods We performed a cohort study including all MS patients treated with MX at the Neurological Department of the University Hospital of Palermo, Italy. Two hundred-sixty-four MS patients diagnosed according to validated criteria were included and followed-up until the end of September 2010. Patients were treated with MX as a second line therapy if they had no prev…

medicine.medical_specialtyImmunologyHeart failureComorbidity030204 cardiovascular system & hematologylcsh:RC346-429Multiple sclerosis03 medical and health sciences0302 clinical medicineInternal medicinemedicineImmunology and AllergyMyocardial infarctionlcsh:Neurology. Diseases of the nervous systemMitoxantroneEjection fractionmedicine.diagnostic_testCumulative dosebusiness.industryComorbidity Multiple sclerosis Heart failure Mitoxantrone Therapymedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareNeurologyHeart failureCohortPhysical therapySettore MED/26 - NeurologiaTherapyNeurology (clinical)MitoxantronebusinessElectrocardiography030217 neurology & neurosurgeryCohort studymedicine.drug
researchProduct

Patent Foramen Ovale and Thromboembolic Complications

2010

The foramen ovale, an atrial septal defect which is essential in the fetal circulation, remains patent through adulthood in approximately 25% of the general population and so it represents the most common persistent abnormality of fetal origin. Patent foramen ovale (PFO) allows interatrial right-to-left blood shunting during those periods of the cardiac cycle in which the right atrial pressure exceeds the left one. An increasing number of pathological manifestations of PFO has been recently identified; among these, paradoxical systemic embolism, refractory hypoxemia in patients with right ventricular myocardium infarction or severe pulmonary disease, orthostatic oxygen desaturation in the r…

medicine.medical_specialtyMagnetic Resonance SpectroscopyPopulationEchocardiography Three-DimensionalForamen secundumForamen Ovale PatentPersistent fetal circulationHypoxemiaPFOThromboembolismDrug DiscoverymedicineHumanseducationForamen ovale (heart)Pharmacologyeducation.field_of_studybusiness.industrySettore MED/23 - Chirurgia Cardiacamedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareThrombosisSurgerymedicine.anatomical_structureEmbolismEchocardiographyPatent foramen ovalemedicine.symptomTomography X-Ray ComputedbusinessEchocardiography TransesophagealCurrent Pharmaceutical Design
researchProduct